ClassID:

20900

A61K38/08 - page 4 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids

Recent Application in this class:
#901
20200268695
2020-08-27

Non-Enzymatic Debriding Agent and Method of Use Thereof

#902
20200268276
2020-08-27

Methods and apparatus for guiding medical care based on detected gastric function

#903
20200263175
2020-08-20

CHANNEL MODULATORS

#904
20200262869
2020-08-20

PEPTIDE ANTIBIOTIC COMPLEXES AND METHODS OF USE THEREOF

#905
20200262868
2020-08-20

Compositions for inducing urinary voiding and defecation

#906
20200261506
2020-08-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#907
20200261505
2020-08-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#908
20200261504
2020-08-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#909
20200254055
2020-08-13

Pharmaceutical compositions and preparations for administration to the eye

#910
20200254052
2020-08-13

Sincalide Formulations

#911
20200247849
2020-08-06

Peptide agonists and antagonists of TLR4 activation

#912
20200247845
2020-08-06

Hemiasterlin derivatives and antibody-drug conjugates including same

#913
20200246419
2020-08-06

Cyclic prosaposin peptides and uses thereof

#914
20200246417
2020-08-06

Angio-3 for treatment of retinal angiogenic diseases

#915
20200239889
2020-07-30

Channel modulators

#916
20200239520
2020-07-30

Anticancer peptides and uses thereof

#917
20200237904
2020-07-30

Methods and Compositions Useful for Treating Cancer

#918
20200237861
2020-07-30

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

#919
20200237854
2020-07-30

Methods of treating prostate cancer with GnRH antagonist

#920
20200231626
2020-07-23

Peptide inhibitors of tight junction permeability

#921
20200230212
2020-07-23

PIC1 inhibition of myeloperoxidase oxidative activity in an animal model

#922
20200222519
2020-07-16

Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancers

#923
20200222496
2020-07-16

TISSUE OCCLUDING AGENT

#924
20200222492
2020-07-16

Method of Reducing Injury to Mammalian Cells

#925
20200222465
2020-07-16

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#926
20200215199
2020-07-09

Compounds for treating cancer

#927
20200215191
2020-07-09

Methods and compositions related to inhibition of viral entry

#928
20200214960
2020-07-09

Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes

#929
20200206315
2020-07-02

Compositions and methods comprising bone morphogenetic protein and NEMO binding peptide

#930
20200206306
2020-07-02

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS

#931
20200206301
2020-07-02

JNK Inhibitor Molecules For Treatment Of Various Diseases

#932
20200206300
2020-07-02

Agent for promoting skeletal muscle injury repair

#933
20200206299
2020-07-02

INHIBITORS OF BETA-ARRESTIN-NEUROKININ 1 RECEPTOR INTERACTIONS FOR THE TREATMENT OF PAIN

#934
20200206268
2020-07-02

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#935
20200197483
2020-06-25

Antibacterial compositions, methods of making and use thereof

#936
20200197441
2020-06-25

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#937
20200197325
2020-06-25

METHODS INVOLVING DOWNREGULATING APOBEC3B

#938
20200197285
2020-06-25

Peptide exhibiting wrinkle-improving activity and uses thereof

#939
20200190144
2020-06-18

Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion

#940
20200188490
2020-06-18

Hyaluronic acid containing compositions for prevention of the formation of post-surgical scars and post-surgical adhesions

#941
20200188473
2020-06-18

COMBINATION THERAPY FOR CANCER

#942
20200188472
2020-06-18

CONJUGATES FOR IMMUNOTHERAPY

#943
20200188471
2020-06-18

APPLICATION OF SELECTIVE TNFR1 ANTAGONIST PEPTIDE SN10 IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS

#944
20200179529
2020-06-11

Cytotoxin and conjugate, uses of same and preparation method therefor

#945
20200179481
2020-06-11

Flounder surimi having antioxidant and antihypertensive effects and method of preparing the same

#946
20200179479
2020-06-11

INHIBITION OF ALPHA5BETA1 INTEGRIN WITH ATN-161 AS A NOVEL THERAPY FOR VASCULAR DEMENTIA

#947
20200179454
2020-06-11

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#948
20200179453
2020-06-11

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#949
20200179285
2020-06-11

BIODEGRADABLE MICROPARTICLES FOR SUSTAINED DELIVERY OF ANTI-ANGIOGENIC PEPTIDE

#950
20200178567
2020-06-11

PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH

#951
20200172598
2020-06-04

METHODS FOR PURIFYING PROTEINS HAVING A TUBULIN CARBOXYPEPTIDASE ACTIVITY AND PEPTIDIC BASED INHIBITORS THEREOF

#952
20200172574
2020-06-04

INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION

#953
20200171160
2020-06-04

Prochelators as targeted prodrugs for prostate cancer and methods of making and using same

#954
20200171120
2020-06-04

Saposin-A derived peptides and uses thereof

#955
20200171091
2020-06-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#956
20200165318
2020-05-28

Compositions comprising D-amino acid peptides and methods of production and use thereof for inhibiting autoantibodies

#957
20200165298
2020-05-28

Inhibition of pulmonary fibrosis with nutlin-3a and peptides

#958
20200164053
2020-05-28

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#959
20200164028
2020-05-28

POLYPEPTIDE THERAPEUTICS AND USES THEREOF

#960
20200163996
2020-05-28

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#961
20200157165
2020-05-21

PEPTIDES HAVING OSTEOBLAST GROWTH-PROMOTING ACTIVITY AND USE THEREOF

#962
20200157149
2020-05-21

Cell permeable cyclic peptide scaffolds

#963
20200155637
2020-05-21

PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE

#964
20200155605
2020-05-21

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#965
20200155604
2020-05-21

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#966
20200147229
2020-05-14

ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES

#967
20200147167
2020-05-14

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

#968
20200138954
2020-05-07

Mixtures and formulations comprising an alkyl ammonium EDTA salt

#969
20200138924
2020-05-07

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#970
20200138898
2020-05-07

METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN

#971
20200129629
2020-04-30

Glycotargeting therapeutics

#972
20200121755
2020-04-23

Therapy for subarachnoid hemorrhage and ischemia

#973
20200113968
2020-04-16

AGONISTS OF GUANYLATE CYCLASE USEFUL FOR DOWNREGULATION OF PRO-INFLAMMATORY CYTOKINES

#974
20200113967
2020-04-16

Peptides and uses therefor as antiviral agents

#975
20200113965
2020-04-16

Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue

#976
20200108159
2020-04-09

Radiotherapeutic and companion imaging agents to target MC1R

#977
20200108117
2020-04-09

Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour

#978
20200108116
2020-04-09

Method for treating lung cancer

#979
20200108097
2020-04-09

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#980
20200101030
2020-04-02

MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME

#981
20200095282
2020-03-26

Peptides capable of reactivating p53 mutants

#982
20200095278
2020-03-26

Peptidyl ketoamides as inhibitors of rhomboid proteases

#983
20200093924
2020-03-26

Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis

#984
20200093862
2020-03-26

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#985
20200087378
2020-03-19

Relaxin1 derived peptides for use in immunotherapy

#986
20200087363
2020-03-19

B*44 restricted peptides for use in immunotherapy against cancers and related methods

#987
20200085961
2020-03-19

Oral formulations of kappa opioid receptor agonists

#988
20200085907
2020-03-19

Adiponectin peptidomimetics for treating ocular disorders

#989
20200085906
2020-03-19

Methods for the treatment of glaucoma and age-related macular degeneration by a peptide D-TRP-AIB

#990
20200085874
2020-03-19

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#991
20200085873
2020-03-19

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#992
20200078442
2020-03-12

DPEP-1 binding compositions and methods of use

#993
20200078438
2020-03-12

Agent for the Treatment of Skin Wounds or Burns

#994
20200078434
2020-03-12

LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES

#995
20200078373
2020-03-12

Synthetic bile acid compositions and methods

#996
20200078362
2020-03-12

COMBINATION THERAPY FOR TREATING CANCER

#997
20200078296
2020-03-12

Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment

#998
20200071407
2020-03-05

Inhibitors of prototypic galectin dimerization and uses thereof

#999
20200069766
2020-03-05

COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING

#1000
20200069765
2020-03-05

Peptides having immunomodulatory properties

#1001
20200061148
2020-02-27

METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS

#1002
20200054764
2020-02-20

MEDICAL USE OF ANTI-C MET ANTIBODY-CYTOTOXIC DRUG CONJUGATE

#1003
20200054713
2020-02-20

Pharmaceutical composition for preventing and treating transplant rejection

#1004
20200054602
2020-02-20

Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease

#1005
20200046819
2020-02-13

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#1006
20200046802
2020-02-13

THERAPEUTIC METHOD USING TOLEROGENIC PEPTIDES

#1007
20200046797
2020-02-13

Methods of treating female infertility

#1008
20200040079
2020-02-06

HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject

#1009
20200040064
2020-02-06

Passive antibody dependent cell-mediated activation

#1010
20200040060
2020-02-06

Peptides and combination of peptides for use in immunotherapy against various tumors

#1011
20200038641
2020-02-06

DRUG DELIVERY DEVICE WITH REMOVABLE PODS AND RELATED PODS, METHODS AND SYSTEMS

#1012
20200038508
2020-02-06

Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

#1013
20200038448
2020-02-06

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#1014
20200038447
2020-02-06

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#1015
20200038446
2020-02-06

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#1016
20200038325
2020-02-06

Liposomal compositions and methods of use

#1017
20200031941
2020-01-30

Monoclonal antibodies against HER2 epitope and methods of use thereof

#1018
20200031921
2020-01-30

Compositions and methods of use of interleukin-10 peptides and anti-interleukin-10 antibodies

#1019
20200031899
2020-01-30

Peptides and combination of peptides for use in immunotherapy against various tumors

#1020
20200031866
2020-01-30

PEPTIDE INHIBITORS OF SODIUM CHANNELS

#1021
20200030406
2020-01-30

Sincalide Formulations

#1022
20200024325
2020-01-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#1023
20200024309
2020-01-23

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

#1024
20200023083
2020-01-23

METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES

#1025
20200023033
2020-01-23

COMPOSITION FOR TREATING PULMONARY FIBROSIS COMPRISING ALLOFERON

#1026
20200023032
2020-01-23

Peptoids and methods for attenuating inflammatory response

#1027
20200023031
2020-01-23

COMPOSITION FOR ANTI-PANCREATIC CANCER AND ANTI-PANCREATIC ADJUVANT COMPRISING ALLOFERON

#1028
20200017563
2020-01-16

Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment

#1029
20200017562
2020-01-16

Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory

#1030
20200017546
2020-01-16

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

#1031
20200016232
2020-01-16

Compositions and methods for regulating blood pressure

#1032
20200010414
2020-01-09

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#1033
20200009237
2020-01-09

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1034
20200009056
2020-01-09

ORGANIC COMPOUNDS

#1035
20200009040
2020-01-09

Topical formulations and methods

#1036
20200000932
2020-01-02

Glycan-interacting compounds and methods of use

#1037
20200000928
2020-01-02

THERAPEUTIC PRODRUGS FOR NEUROLOGIC MALADIES

#1038
20200000874
2020-01-02

PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME

#1039
20200000871
2020-01-02

B-1A LYMPHOCYTE AND/OR MACROPHAGE TARGETING AND ACTIVATION TO TREAT MEDICAL CONDITIONS WITH INFLAMMATORY OR AUTOIMMUNE COMPONENTS

#1040
20200000787
2020-01-02

MEDICAMENT FOR TREATMENT OF LIVER CANCER

#1041
20190389905
2019-12-26

Peptide inhibitors targeting the pivotal anaerobic respiration factor AniA

#1042
20190388551
2019-12-26

Nucleic acid constructs and methods of using the same

#1043
20190388504
2019-12-26

CAPCNA PEPTIDE THERAPEUTICS FOR CANCER

#1044
20190388495
2019-12-26

Pharmaceutical Composition for Preventing or Treating Hypersensitivity Immune Disease, and Method for Producing Same

#1045
20190388494
2019-12-26

THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS

#1046
20190382468
2019-12-19

Methods and compositions for the treatment of cancer

#1047
20190382449
2019-12-19

Universal antivenom

#1048
20190382444
2019-12-19

Zinc-binder based EBNA1-specific compounds

#1049
20190382443
2019-12-19

Cyclic peptide epitopes and small-molecule mimics for inducing autophagy

#1050
20190381128
2019-12-19

GLP-1 Secretagogue and Composition

#1051
20190381127
2019-12-19

COMBINATION THERAPY WITH A6, CHEMOTHERAPEUTIC AGENTS, RADIATION THERAPY, OR A COMBINATION THEREOF FOR THE TREATMENT OF CANCER

#1052
20190380957
2019-12-19

Protein Hydrogels For Treatment Of Neovascular Disease

#1053
20190380952
2019-12-19

Immunostimulatory method

#1054
20190375790
2019-12-12

Multi-target peptide molecules of opioid and neuropeptide FF receptor, preparation for molecules, and applications thereof

#1055
20190374651
2019-12-12

Anti-5T4 antibody-drug conjugate and use thereof

#1056
20190374599
2019-12-12

Conjugate of salicylic acid and peptide

#1057
20190374596
2019-12-12

PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME

#1058
20190365920
2019-12-05

Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the MAPK pathway

#1059
20190365911
2019-12-05

HSP90 inhibitory peptide conjugate and application thereof in treating tumor

#1060
20190365859
2019-12-05

Preventive or therapeutic method for inflammatory skin disease

#1061
20190365848
2019-12-05

Treatment of ascites

#1062
20190365847
2019-12-05

IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF

#1063
20190359962
2019-11-28

Antimicrobial agents against

#1064
20190359669
2019-11-28

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#1065
20190358289
2019-11-28

Compositions and methods for treating disease associated with permeability of intestinal epithelium

#1066
20190358288
2019-11-28

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ENVIRONMENTAL ENTEROPATHY

#1067
20190358287
2019-11-28

Methods for ameliorating memory impairment in a memory disorder caused by neuronal cell death or Abeta aggregation using a peptide

#1068
20190358144
2019-11-28

Compositions comprising peptide WKDEAGKPLVK

#1069
20190353642
2019-11-21

CD2-associated protein (CD2AP) and its interactive proteins

#1070
20190351016
2019-11-21

C3A receptor agonists for use against ischemic brain injury, stroke, traumatic brain injury, spinal cord injury and neurodegenerative disorders

#1071
20190351013
2019-11-21

Arginine-rich polypeptide compositions and methods of using same

#1072
20190351008
2019-11-21

Methods and compositions for modulating opioid withdrawal symptoms

#1073
20190343922
2019-11-14

HISTATIN FOR CORNEAL WOUND HEALING AND OCULAR SURFACE DISEASE

#1074
20190343914
2019-11-14

Peptidomimetic macrocycles

#1075
20190343913
2019-11-14

Methods and compositions for the treatment of neuropathy and hyperalgesia

#1076
20190338000
2019-11-07

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#1077
20190336574
2019-11-07

Use of peptides that block metadherin-SND1 interaction as treatment for cancer

#1078
20190336567
2019-11-07

Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use

#1079
20190330289
2019-10-31

GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, RENAL NEPHRONS AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR

#1080
20190330271
2019-10-31

Polypeptide binding to a plurality of amyloid monomers and aggregates, and use thereof

#1081
20190328910
2019-10-31

Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

#1082
20190328895
2019-10-31

Antibody-drug conjugates

#1083
20190328891
2019-10-31

MEDICAL PREPARATION WITH A CARRIER BASED ON HYALURONAN AND/OR DERIVATIVES THEREOF, METHOD OF PREPARATION AND USE THEREOF

#1084
20190328856
2019-10-31

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1085
20190328838
2019-10-31

COMPOSITIONS COMPRISING IL-2 FUSION PROTEINS AND METHODS FOR TREATING NEOPLASIA

#1086
20190328826
2019-10-31

Compositions and methods for treating cancer and persistent viral infections

#1087
20190328825
2019-10-31

METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS

#1088
20190328824
2019-10-31

HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE

#1089
20190328823
2019-10-31

Composition comprising protein phosphatase 1 inhibitory peptide for treating vascular diseases

#1090
20190328821
2019-10-31

METHODS FOR REDUCING OXIDATIVE DAMAGE

#1091
20190321495
2019-10-24

Compositions and methods of treating melanoma

#1092
20190321471
2019-10-24

COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB

#1093
20190321438
2019-10-24

Use of a compound, pharmaceutical composition, and therapeutic method for the treatment or prevention of convulsions

#1094
20190315823
2019-10-17

SMALL CATIONIC ANTI-BIOFILM AND IDR PEPTIDES

#1095
20190315804
2019-10-17

Peptides capable of reactivating p53 mutants

#1096
20190314556
2019-10-17

Tyrosine peptide cross-linked biocompatible hydrogel and method of production

#1097
20190314517
2019-10-17

Stable anti-CD79B immunoconjugate formulations

#1098
20190314515
2019-10-17

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#1099
20190314497
2019-10-17

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS

#1100
20190314446
2019-10-17

VAP polypeptide and use thereof in preparation of drug for targeted diagnosis and treatment of tumor

#1101
20190314445
2019-10-17

Activation and expansion of NKG2C+ NK cells

#1102
20190309018
2019-10-10

Peptides useable for treating cancer

#1103
20190307842
2019-10-10

Methods for treating bone loss using sclerostin peptides

#1104
20190307834
2019-10-10

Composition for controlled release of therapeutic agents

#1105
20190307833
2019-10-10

TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH NEUROTROPHIC PEPTIDERGIC COMPOUND

#1106
20190307832
2019-10-10

Inhibitors of valosin-containing protein and methods of use

#1107
20190307830
2019-10-10

Compositions targeting the interaction domain between p27Kip1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity

#1108
20190300886
2019-10-03

Visceral adipose tissue macrophage-targeted gene/carrier complex for preventing or treating obesity-induced type II diabetes

#1109
20190300595
2019-10-03

Peptides and combination of peptides for use in immunotherapy against various tumors

#1110
20190298793
2019-10-03

Method for lowering low density lipoproteins

#1111
20190298792
2019-10-03

Method of treating diseases

#1112
20190298686
2019-10-03

Methods of treating Prader-Willi syndrome

#1113
20190290729
2019-09-26

PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF

#1114
20190290719
2019-09-26

MEDICAL DEVICES

#1115
20190285074
2019-09-19

Stable liquid formulation of AMG 416 (etelcalcetide)

#1116
20190276513
2019-09-12

Synthetic somatostatin receptor ligands

#1117
20190275129
2019-09-12

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#1118
20190275105
2019-09-12

Prelyophilized, lyophilized and reconstituted formulations comprising TAT-NR2B9C with d-amino acids, histidine and trehalose

#1119
20190270778
2019-09-05

Cyclic Peptides As C5a Receptor Antagonists

#1120
20190270775
2019-09-05

Polypeptide and use thereof

#1121
20190270774
2019-09-05

Peptide with anti-obesity and anti-diabetes activity and use thereof

#1122
20190270773
2019-09-05

Peptide with anti-obesity and anti-diabetes activity and use thereof

#1123
20190270772
2019-09-05

Peptide with anti-obesity and anti-diabetes activity and use thereof

#1124
20190270771
2019-09-05

Peptides derived from the propeptide NTSR3 and their use in the treatment of depression

#1125
20190269791
2019-09-05

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

#1126
20190269751
2019-09-05

Method for lowering triglyceride

#1127
20190269750
2019-09-05

PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING FEMALE SEXUAL DYSFUNCTIONS

#1128
20190263864
2019-08-29

Polypeptide and use thereof

#1129
20190263861
2019-08-29

Agonists of guanylate cyclase and their uses

#1130
20190262445
2019-08-29

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#1131
20190262419
2019-08-29

Formulations containing a somatostatin receptor agonist

#1132
20190262418
2019-08-29

Compositions and methods for invasive and non-invasive procedural skincare

#1133
20190262387
2019-08-29

Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications

#1134
20190255164
2019-08-22

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#1135
20190255141
2019-08-22

GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES

#1136
20190255140
2019-08-22

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

#1137
20190255113
2019-08-22

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#1138
20190255112
2019-08-22

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#1139
20190255110
2019-08-22

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#1140
20190255082
2019-08-22

Enhancement of CD47 blockade therapy by proteasome inhibitors

#1141
20190248833
2019-08-15

METHODS FOR REDUCING CD36 EXPRESSION

#1142
20190248832
2019-08-15

Alpha-v beta-6 integrin ligands and uses thereof

#1143
20190247540
2019-08-15

Composition comprising self-assembling peptides for use in treatment of gingivitis, periodontitis and/or peri-implantitis

#1144
20190241663
2019-08-08

Anti-B7-H4 antibodies and immunoconjugates

#1145
20190240292
2019-08-08

METHODS OF ADMINISTERING HEPCIDIN

#1146
20190240283
2019-08-08

Nutritional supplements containing a peptide component and uses thereof

#1147
20190240282
2019-08-08

Nanocage

#1148
20190233567
2019-08-01

Polymeric nanoparticles useful in theranostics

#1149
20190233490
2019-08-01

Method of synthesizing antagonist peptides for cell growth

#1150
20190231746
2019-08-01

Opioid agonist peptides and uses thereof

#1151
20190225684
2019-07-25

REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS

#1152
20190225660
2019-07-25

METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS

#1153
20190224279
2019-07-25

PHARMACEUTICAL ASSOCIATION COMPRISING A GROWTH FACTOR RECEPTOR AGONIST CONJUGATED TO A BIOACTIVE CARRIER FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF

#1154
20190224273
2019-07-25

Nutritional supplements containing a peptide component and uses thereof

#1155
20190224272
2019-07-25

Inhibiting tumor cell migration by inhibition of kinesin light chain 1, variant 1 (KLC1C)

#1156
20190224271
2019-07-25

Manufacture of Degarelix

#1157
20190224270
2019-07-25

PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS

#1158
20190219601
2019-07-18

Methods and kits for assessing Heparanase procoagulant activity, compositions comprising Heparanase, and methods for the treatment of coagulation-related disorders

#1159
20190216900
2019-07-18

Methods of treating mild brain injury

#1160
20190212344
2019-07-11

BIOMARKERS FOR USE IN DETERMINING RESPONSE TO TREATMENT OF NEURODEGENERATION DISEASE

#1161
20190211060
2019-07-11

Cyclic peptide analogs and conjugates thereof

#1162
20190209715
2019-07-11

Plectin-1 Targeted Agents for Detection and Treatment of Pancreatic Ductal Adenocarcinoma

#1163
20190209660
2019-07-11

PIC1 inhibition of myeloperoxidase oxidative activity in an animal model

#1164
20190209643
2019-07-11

Low-burst polymers and methods to produce polymer

#1165
20190204340
2019-07-04

USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME

#1166
20190202860
2019-07-04

Peptide having anticancer activity, and pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and treating cancer comprising the same as active ingredient

#1167
20190201539
2019-07-04

Synthetic compound

#1168
20190201477
2019-07-04

Compositions and methods for the treatment of neurodamage

#1169
20190194253
2019-06-27

Peptides and compositions comprising same and uses thereof in the treatment of diseases

#1170
20190192613
2019-06-27

Composition for preventing or treating hyperoxia-induced lung injury comprising WKYMVm peptide as an active ingredient

#1171
20190185540
2019-06-20

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#1172
20190177367
2019-06-13

AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING

#1173
20190175644
2019-06-13

METHODS FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY EXTRACELLULAR MICROORGANISMS, INCLUDING ANTIMICROBIAL-RESISTANT STRAINS THEREOF, USING GALLIUM COMPOUNDS

#1174
20190175626
2019-06-13

Cancer therapy

#1175
20190175528
2019-06-13

INHIBITION OF BIOFILM ORGANISMS

#1176
20190167803
2019-06-06

TLR9 TARGETED CYTOTOXIC AGENTS

#1177
20190167759
2019-06-06

ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF

#1178
20190167755
2019-06-06

METHODS FOR TREATING METASTATIC STAGE PROSTATE CANCER

#1179
20190167754
2019-06-06

PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF SOMATOSTATIN ANALOGS

#1180
20190167634
2019-06-06

Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances

#1181
20190161525
2019-05-30

Method for treating Alzheimer's disease and method for downregulating protein aggregation in brain

#1182
20190160141
2019-05-30

Dosing regimens for echinocandin class compounds

#1183
20190151402
2019-05-23

Method of treating cancer cells

#1184
20190151401
2019-05-23

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

#1185
20190151310
2019-05-23

Toxic RNA inhibitors self-assembled in situ

#1186
20190144562
2019-05-16

Antibodies, uses thereof and conjugates thereof

#1187
20190144501
2019-05-16

Compounds and pharmaceutical use thereof in the treatment of cancer

#1188
20190144500
2019-05-16

Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment

#1189
20190135898
2019-05-09

Method and pharmaceutical composition for use in the treatment of cancer

#1190
20190135873
2019-05-09

Compositions and methods for treating diseases by inhibiting exosome release

#1191
20190134211
2019-05-09

CAR PEPTIDE FOR HOMING, DIAGNOSIS & TARGETED THERAPY FOR PULMONARY AND FIBROTIC DISORDERS

#1192
20190134151
2019-05-09

Antibacterial compositions, methods of making and use thereof

#1193
20190134146
2019-05-09

Methods comprising desmopressin

#1194
20190134144
2019-05-09

Methods for treating autism spectrum disorder and associated symptoms

#1195
20190134143
2019-05-09

Therapeutic peptides for excitatory neurotoxicity-related injuries

#1196
20190133952
2019-05-09

PREPARATION METHOD OF SUSTAINED-RELEASE MICROPARTICLES

#1197
20190125823
2019-05-02

Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a person with pain

#1198
20190119352
2019-04-25

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#1199
20190119351
2019-04-25

Peptides and combination of peptides for use in immunotherapy against various tumors

#1200
20190119321
2019-04-25

Peptide showing melanin generation-promoting activity and use thereof